Erin L. Milliken

549 total citations
9 papers, 413 citations indexed

About

Erin L. Milliken is a scholar working on Pathology and Forensic Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Erin L. Milliken has authored 9 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Oncology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Erin L. Milliken's work include Growth Hormone and Insulin-like Growth Factors (3 papers), Cancer Cells and Metastasis (2 papers) and Hypothalamic control of reproductive hormones (1 paper). Erin L. Milliken is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (3 papers), Cancer Cells and Metastasis (2 papers) and Hypothalamic control of reproductive hormones (1 paper). Erin L. Milliken collaborates with scholars based in United States, United Kingdom and India. Erin L. Milliken's co-authors include Ruth A. Keri, Katherine B. Roland, Susan M. White, Elizabeth A. Rohan, Amy DeGroff, Paul Young, Stephanie Melillo, Thomas J. Kelley, Assem Ziady and Thomas W. Ferkol and has published in prestigious journals such as Oncogene, Endocrinology and Cancer Letters.

In The Last Decade

Erin L. Milliken

9 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin L. Milliken United States 9 122 89 81 75 62 9 413
Eleanor L. Watts United Kingdom 14 88 0.7× 73 0.8× 27 0.3× 74 1.0× 68 1.1× 28 430
Brent Diekmann United States 9 149 1.2× 135 1.5× 176 2.2× 25 0.3× 133 2.1× 9 532
Henrikki Santti Finland 13 147 1.2× 87 1.0× 110 1.4× 178 2.4× 66 1.1× 25 603
Elisabeth C. Inwald Germany 10 167 1.4× 64 0.7× 18 0.2× 60 0.8× 33 0.5× 32 430
Karen Lin United States 13 212 1.7× 49 0.6× 46 0.6× 49 0.7× 39 0.6× 22 612
Jeetendra Eswaraka United States 10 76 0.6× 62 0.7× 19 0.2× 132 1.8× 31 0.5× 11 431
Soung-Hoon Chang South Korea 14 81 0.7× 39 0.4× 68 0.8× 55 0.7× 79 1.3× 38 563
Mahmood Alam United States 11 118 1.0× 17 0.2× 36 0.4× 63 0.8× 41 0.7× 28 418
Sabrina Gill Canada 14 82 0.7× 105 1.2× 39 0.5× 108 1.4× 139 2.2× 39 665
Mohammad H. Al‐Qahtani Saudi Arabia 11 25 0.2× 60 0.7× 61 0.8× 77 1.0× 64 1.0× 41 385

Countries citing papers authored by Erin L. Milliken

Since Specialization
Citations

This map shows the geographic impact of Erin L. Milliken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin L. Milliken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin L. Milliken more than expected).

Fields of papers citing papers by Erin L. Milliken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin L. Milliken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin L. Milliken. The network helps show where Erin L. Milliken may publish in the future.

Co-authorship network of co-authors of Erin L. Milliken

This figure shows the co-authorship network connecting the top 25 collaborators of Erin L. Milliken. A scholar is included among the top collaborators of Erin L. Milliken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin L. Milliken. Erin L. Milliken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kim, Paula & Erin L. Milliken. (2018). Minority Participation in Biobanks: An Essential Key to Progress. Methods in molecular biology. 1897. 43–50. 10 indexed citations
2.
Roland, Katherine B., Erin L. Milliken, Elizabeth A. Rohan, et al.. (2017). Use of Community Health Workers and Patient Navigators to Improve Cancer Outcomes Among Patients Served by Federally Qualified Health Centers: A Systematic Literature Review. Health Equity. 1(1). 61–76. 159 indexed citations
3.
Milliken, Erin L., et al.. (2010). Cancer Education and Effective Dissemination: Information Access is not Enough. Journal of Cancer Education. 25(2). 196–205. 11 indexed citations
5.
Casadesús, Gemma, Erin L. Milliken, Kate M. Webber, et al.. (2007). Increases in luteinizing hormone are associated with declines in cognitive performance. Molecular and Cellular Endocrinology. 269(1-2). 107–111. 87 indexed citations
6.
Milliken, Erin L., Kristen L. Lozada, Melissa D. Landis, et al.. (2007). Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer. Oncogene. 27(12). 1759–1766. 8 indexed citations
7.
Milliken, Erin L., Xiaoxue Zhang, Chris A. Flask, et al.. (2005). EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer. Cancer Letters. 229(2). 205–215. 22 indexed citations
8.
Ziady, Assem, Thomas J. Kelley, Erin L. Milliken, Thomas W. Ferkol, & Pamela B. Davis. (2002). Functional Evidence of CFTR Gene Transfer in Nasal Epithelium of Cystic Fibrosis Mice in Vivo Following Luminal Application of DNA Complexes Targeted to the Serpin-Enzyme Complex Receptor. Molecular Therapy. 5(4). 413–419. 53 indexed citations
9.
Milliken, Erin L., Rebecca Ameduri, Melissa D. Landis, et al.. (2002). Ovarian Hyperstimulation by LH Leads to Mammary Gland Hyperplasia and Cancer Predisposition in Transgenic Mice. Endocrinology. 143(9). 3671–3680. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026